Search

Search Results
Results 4781 - 4790 of 4839 for multiple sclerosis
  • Kombiglyze XR
    Drug - 19 Feb 2026
    Consumer Medicine Information (CMI) about Kombiglyze XR intended for persons living in Australia.
  • Whole brain network imaging using functional ultrasound (fUS)
    White Paper - 9 Feb 2026
    An overview of the principles and advantages of functional ultrasound imaging for brain and neuropharmacology research.
  • Opsynvi
    Drug - 6 Feb 2026
    Consumer Medicine Information (CMI) about Opsynvi intended for persons living in Australia.
  • Remicade
    Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Actemra
    Drug - 16 Jan 2026
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Ixifi
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Ixifi intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Dapa-Tabs intended for persons living in Australia.
  • Perisyl Combi
    Drug - 9 Dec 2025
    Consumer Medicine Information (CMI) about Perisyl Combi intended for persons living in Australia.
  • Cimzia
    Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Cimzia intended for persons living in Australia.
  • Codalgin Forte
    Drug - 6 Nov 2025
    Consumer Medicine Information (CMI) about Codalgin Forte intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback